Comparison of two high doses of oral methylprednisolone for multiple sclerosis relapses: a pilot, multicentre, randomized, double ‐blind, non‐inferiority trial

ConclusionsA lesser high ‐dose oral methylprednisolone regimen may not be inferior to the standard high dose in terms of clinical and radiological response.

Source: European Journal of Neurology - November 16, 2018 Category: Neurology Authors: J. V. Herv ás‐García, L. Ramió‐Torrentà, L. Brieva‐Ruiz, J. Batllé‐Nadal, E. Moral, Y. Blanco, A. Cano‐Orgaz, S. Presas‐Rodríguez, F. Torres, J. Capellades, C. Ramo‐Tello Tags: Original Article Source Type: research